Cell growth and proliferation require coordinated ribosomal biogenesis and translation. Eukaryotic initiation factors (eIFs) control translation at the rate-limiting step of initiation 1, 2 . So far, only two eIFs connect extracellular stimuli to global translation rates 3 : eIF4E acts in the eIF4F complex and regulates binding of capped messenger RNA to 40S subunits, downstream of growth factors 4, 5 , and eIF2 controls loading of the ternary complex on the 40S subunit and is inhibited on stress stimuli 6, 7 . No eIFs have been found to link extracellular stimuli to the activity of the large 60S ribosomal subunit. eIF6 binds 60S ribosomes precluding ribosome joining in vitro [8] [9] [10] . However, studies in yeasts showed that eIF6 is required for ribosome biogenesis rather than translation [11] [12] [13] [14] . Here we show that mammalian eIF6 is required for efficient initiation of translation, in vivo. eIF6 null embryos are lethal at preimplantation. Heterozygous mice have 50% reduction of eIF6 levels in all tissues, and show reduced mass of hepatic and adipose tissues due to a lower number of cells and to impaired G1/S cell cycle progression. eIF6
1/2 cells retain sufficient nucleolar eIF6 and normal ribosome biogenesis. The liver of eIF6 1/2 mice displays an increase of 80S in polysomal profiles, indicating a defect in initiation of translation. Consistently, isolated hepatocytes have impaired insulin-stimulated translation. Heterozygous mouse embryonic fibroblasts recapitulate the organism phenotype and have normal ribosome biogenesis, reduced insulin-stimulated translation, and delayed G1/S phase progression. Furthermore, eIF6
1/2 cells are resistant to oncogene-induced transformation. Thus, eIF6 is the first eIF associated with the large 60S subunit that regulates translation in response to extracellular signals.
The eIF6 gene was deleted by homologous recombination using embryonic stem cell technology ( Supplementary Fig. 1 ). The portion of the gene containing the first two exons and the first two introns was substituted by a cassette containing the neomycin resistance gene. The presence of the neomycin resistance cassette did not affect expression of wild-type eIF6 and of adjacent genes (Supplementary Fig. 2 ). Germ-line transmission was achieved, and intercrossing of eIF6 heterozygous mice did not produce any eIF6 2/2 offspring. We did not observe eIF6 2/2 mice as early as 3.5 days post coitum, indicating that eIF6 is essential for proper development at the stage of preimplantation (Supplementary Table 1 ). The lethality of eIF6 2/2 embryos is consistent with the early expression of the protein in the blastocysts ( Supplementary Fig. 1d ).
Heterozygous eIF6 1/2 mice were viable and indistinguishable from wild-type counterparts up to 30 days after birth. At three months of age, heterozygous mice, independently from gender and genetic background, weighed less than their wild-type littermates (Fig. 1a) . The head-anus length of eIF6 1/2 and wild-type mice was identical (Fig. 1b) , suggesting that the reduction of body mass in eIF6 1/2 mice could be due to the smaller size of specific organs. Biometric measures of eIF6 1/2 and wild-type organs at autopsy revealed that heart and brain were equal to those in wild type, whereas all other organs from eIF6 1/2 mice showed a slight trend to mass reduction (not shown). When the weight of the organs was normalized to the body weight of the corresponding animal, for most organs the differences disappeared, whereas the liver (Fig. 1c) and the adipose tissue ( Supplementary Fig. 3 ) exhibited a reduction in their weight/body ratio. A reduction in liver mass could be due to a reduction in cell number, or to a reduction in cell size. Histological staining showed that the liver of eIF6 1/2 mice was normal ( Supplementary  Fig. 4b, d) , and further morphometric analysis excluded differences in cell size ( Supplementary Fig. 4a, c) . In contrast, we observed fewer cycling cells in the liver of eIF6 1/2 mice (Fig. 1d, e) , suggesting that its reduced mass was due to a reduction in cell number. We performed a similar analysis on adipocytes derived from mesenchymal stem cells: in summary, we found that the reduction of adipose tissue was due to a decreased proliferation of pre-adipocytes, whereas the lipid content per cell was constant ( Supplementary Fig. 3 ). We conclude that the reduction in liver and fat tissue is probably due to a cell autonomous defect marked by reduced proliferative capability.
Quantitative western blotting analysis of eIF6 levels showed that the levels of eIF6 in all heterozygous organs were reduced to half that of the wild type ( Fig. 1f; Supplementary Fig. 3c for fat tissue). In spite of reduction of eIF6 levels, we did not detect obvious phenotypes, in vivo, in other organs, including the skin ( Supplementary Fig. 5 ), where we reported binding of eIF6 (p27BBP) to b 4 integrin 15 . The reduction of eIF6 in all organs from heterozygous mice suggests that under specific circumstances eIF6 haploinsufficiency may become rate-limiting.
We performed polysomal profiles of livers from eIF6 1/2 and eIF6 1/1 littermates. Approximately 30% of the heterozygous/wildtype couples analysed did not present detectable differences in polysomal profiles. In the remaining 70% heterozygous/wild-type couples, in eIF6 1/2 mice polysomal profiles showed an increased 80S peak, accompanied by decreased polysomes (Fig. 2a) ; this suggests that in mammalian liver eIF6 1/2 hepatocytes have a defect in initiation of translation rather than in ribosome biogenesis. We tested this hypothesis using insulin to stimulate basal translation on primary hepatocytes ex vivo 16 . We found that insulin administration led to an increase of methionine incorporation in eIF6 1/1 hepatocytes, but had little or no effect in eIF6 1/2 hepatocytes (Fig. 2b) . We explored further primary mouse embryonic fibroblasts (MEFs) from eIF6 1/2 mice. Remarkably, primary MEFs from eIF6 1/2 mice showed a phenotype identical to liver hepatocytes with an accumulation of the 80S peak (Fig. 2c) and a reduction in insulinstimulated translation (Fig. 2d) , demonstrating that eIF6 depletion alters translation in different cell types. We previously reported that phorbol 12-myristate 13-acetate (PMA) stimulated methionine incorporation in conditions of eIF6 overexpression 10 . We tested whether PMA-stimulated methionine incorporation was reduced in eIF6
1/2 cells, and found that it was ( Supplementary Fig. 6 ). To understand whether basal translation was affected in conditions of eIF6 haploinsufficiency, we pooled data from different experiments. In brief, basal translation is slightly affected in primary hepatocytes, but not in MEFs, consistent with the observation that, in vivo, only liver development is affected by eIF6 haploinsufficiency (Supplementary Fig. 7) .
We decided to test whether the reduction in methionine incorporation observed in conditions of eIF6 haploinsufficiency could be . e, f, Lentiviral-induced re-expression of wild-type eIF6 in MEFs results in de novo insulin stimulation of methionine incorporation (e), whereas lentiviral-induced re-expression of eIF6
Ser235Ala does not (f). All data represent mean 6 s.d. of three independent experiments. *P # 0.01, **P # 0.05.
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LETTERS due to an indirect inactivation of the mTOR (also known as Frap1) pathway, which regulates translation at the level of initiation. We found that in MEFs, the activation of the PI(3)K-mTOR pathway, measured through the phosphorylation of Akt, rpS6 and 4E-BP1 (also known as Eif4ebp1), was normal ( Supplementary Fig. 8 ). The levels of insulin receptor were also normal ( Supplementary Fig. 9 ).
MEFs reconstituted with eIF6 to wild-type levels of eIF6 (Supplementary Fig. 10 ) regained insulin responsiveness (Fig. 2e) , ruling out indirect effects due to chronic eIF6 depletion. To establish whether translation impairment might be due to the anti-association activity of eIF6, we exploited a Ser235Ala mutant, unable to be released from 60S, in vitro, after phosphorylation as we previously described 10 . Heterozygous MEFs reconstituted with eIF6(Ser235Ala) mutant ( Supplementary Fig. 10) were not stimulated by insulin and behaved as eIF6 1/2 cells (Fig. 2f ). We evaluated in detail whether eIF6 haploinsufficiency can lead to deficits in ribosome biogenesis. In brief, the ratio of free 40S to 60S in eIF6 1/2 MEFs was equal to that in eIF6 1/1 MEFs, both in the cytoplasm and in the nucleus ( Supplementary Fig. 11 ). The fact that eIF6 1/2 MEFs show altered translation and normal ribosome biogenesis can be explained by specific reduction of eIF6 in the cytoplasm, but not in nucleoli. Notably, the reduction of eIF6 that we observed in the cytoplasm of eIF6 1/2 cells was more conspicuous than the reduction in the nucleus ( Supplementary Fig. 12a ). In addition, the (apparent) amount of nucleolar-associated eIF6 was identical in wild-type and heterozygous cells (Fig. 3a) .
To investigate whether subtle alterations in ribosome biogenesis could be observed in conditions of haploinsufficiency, we analysed by northern blotting the integrity of the ribosomal RNA processing pathway ( Fig. 3b ) in MEFs and liver. Our data show that the steady-state level of the rRNA precursors 47/45S, 32S and mature 28S is identical in wild-type and eIF6
1/2 cells (Fig. 3b, c) . MEFs from early passages (P2/P3) rapidly grow in culture, allowing also for quantitative analysis of rRNA biogenesis 17 by pulse-chase with radiolabelled uridine. We found that eIF6 1/2 MEFs process rRNA with normal kinetics (Supplementary Fig. 12c ). We also analysed by quantitative polymerase chain reaction with reverse transcription (Q-RT-PCR) the levels of eIF6 messenger RNA, and two ribosomal proteins rpL5 and rpS19. Our data showed that primary eIF6
MEFs have 50% reduction of eIF6 mRNA, but no other ribosomeassociated proteins, both at the level of mRNA and of protein ( Supplementary Fig. 12d, e) . Finally, we asked whether a further reduction of eIF6 could lead to a defect in rRNA biogenesis. Eighty per cent depletion of eIF6 by RNA interference in NIH 3T3 cells ( Supplementary Fig. 13 ) showed normal rRNA synthesis (Fig. 3d) and detectable eIF6 in the nucleolus (Fig. 3e) . Taken together, these data suggest that the reduction of cytoplasmic eIF6 leads to an increase in the steady-state levels of 80S, accompanied by an impairment of the capability of cells to upregulate protein synthesis on insulin stimulation, but a small amount of eIF6 is sufficient for rRNA biogenesis-in other words, eIF6 is an initiation factor in vivo.
We analysed the consequences of eIF6 depletion on cell cycle progression in normal and highly proliferative cells. In early passages, eIF6 1/2 MEFs proliferated similarly to wild type, and had equal replicative senescence ( Supplementary Fig. 14a, b) , rate of apoptosis ( Supplementary Fig. 14c, d ) and cell size ( Supplementary Fig. 14e ). In these conditions, cell cycle distribution by fluorescence-activated cell sorting (FACS) analysis of exponentially growing MEFs derived from eIF6 wild type and matched heterozygous did not show gross differences (Fig. 4a) . Next, we analysed cell cycle progression in cells synchronized by serum starving and stimulated by serum refeeding. Data obtained by 3 H-thymidine labelling show that eIF6 1/2 MEFs enter S-phase 18 h after stimulation (Fig. 4b) , compared to the 12 h required by wild-type cells. These data show that eIF6 haploinsufficiency affects translation and S-phase entry under specific conditions. We looked for additional models in which eIF6 haploinsufficiency could cause a phenotype. eIF6 is overexpressed in cancer cells 18, 19 . We decided to test whether eIF6 haploinsufficient MEFs were efficiently transformed by infection with retroviral vectors encoding dominant-negative (DN)p53 and H-ras V12 , or Myc and H-ras V12 . eIF6 1/2 MEFs formed fewer transformed colonies in soft agar when infected with oncogene-carrying retroviruses compared to wild type (Fig. 4c, d ). We had similar results in the focus formation assay ( Supplementary Fig. 15a, b) . The large difference in the transformation efficiency was not due to differences in retroviral infection and integration (Supplementary Fig. 15c) .
Whether eIF6 is a true initiation factor has been unclear for a long time. The effect of eIF6, in vitro, ranges from no effects on translation to mild stimulation at low doses accompanied by repression at high doses [8] [9] [10] . The difference in the results and in the systems used did not allow a final conclusion. Tif6 (yeast homologue of mammalian eIF6)
Ctrl siRNA depletion led to the loss of 60S biogenesis and rRNA processing defects [11] [12] [13] [14] . In yeasts, most of Tif6 seems to be localized in the nucleus 20,21 and in pre-ribosomal particles 22 , thus raising questions regarding the physiological relevance of the regulated eIF6 anti-association activity. The results we obtained in eIF6 knockout mice demonstrate that eIF6 may be rate-limiting for translation, in vivo, where it may behave as a stimulatory translation initiation factor downstream insulin/growth factors. From this perspective, eIF6 is the first 60S associated initiation factor able to modulate translation downstream of extracellular signalling in vivo. These data do not contradict a role of eIF6 in ribosome biogenesis, but suggest that ribosome biogenesis requires only sequestration of a (minor) nucleolar pool of eIF6.
It remains to be understood whether eIF6 regulates global translation or specific classes of mRNA. It was recently proposed that eIF6 is the mediator regulating microRNA-mediated repression 23 in Caenorhabditis elegans and HeLa cells although not in Drosophila 24 . In conditions of eIF6 heterozygosity we did not observe differences in expression of microRNA targets (Supplementary Fig. 16 ). Further studies are required.
eIF6 is consistently overexpressed in a variety of cancers including colon 18 carcinomas and leukaemias 19 . In the latter context, eIF6 upregulation was interpreted as a by-product of transformation, namely increased growth demanded of ribosomes and translation. Our data support a model in which the levels of eIF6 may directly affect tumorigenesis. In any case, our observations strengthen the concept that translational control is crucial for malignancy, as it was recently proposed for eIF4E, downstream of the mTOR pathway 5 .
METHODS SUMMARY
All analyses were performed at least three times on different genetic backgrounds. For the generation of knockout mice, we deleted exons 1 and 2.
Hepatocytes and primary MEFs were prepared from littermates and kept in culture for 3 h and 2-3 weeks, respectively. Infection and rescue by eIF6-lentivirus were as detailed in Methods . Foci were counted 2-3 weeks after the primary infection 26 . SDS-PAGE and western blotting analyses were performed on total extracts in RIPA buffer (10 mM Tris-Hcl, pH 7.2, 1% sodium deoxycholate, 1% Triton X-100, 0.1% SDS, 150 mM NaCl, 1 mM EDTA, pH 8.0) as detailed elsewhere 17 . Nuclear-cytoplasmic fractionation was performed by ultracentrifugation on a sucrose cushion as described in Supplementary Methods. The purity of the fractions was checked by antibodies against Gapdh (cytoplasm) or histone H2B (also known as Hist2h2be, nucleus). We loaded equivalent amounts of cells.
Cell number and viability were analysed as previously described 27 . S-phase entry was analysed by the 3 H-thymidine assay on primary embryo fibroblasts at early passages.
Full Methods and any associated references are available in the online version of the paper at www.nature.com/nature. 28 and Gapdh (Chemicon International). Nuclear staining was performed with Hoechst 3342 (Molecular Probes). Human insulin was from Sigma. Generation of eIF6 null mice. eIF6 gene retrieval was obtained by screening a mouse genomic DNA library (SJ129 strain). The gene was cloned into a pPNT plasmid. The 59 long arm spanned to the exon 1 and the 39 short arm included exon 3 and exon 4. The construct was electroporated in SJ129 embryonic stem cells by the Core Facility for Conditional Mutagenesis (CFCM). eIF6 mutant cells obtained by homologous recombination were identified by Southern blot and PCR analysis (Supplementary Methods). Recombined embryonic stem cells were used to produce chimaeric animals by both injection and aggregation techniques. Chimaeras were then mated to SJ129 mice for germline transmission. Backcross was performed to the CL57Bl6 background. Genotyping analysis was performed by PCR on tail genomic DNA (Supplementary Methods). Controls for the proper expression of upstream and downstream genes to eIF6 (Itgb4bp) were performed by RT-PCR as detailed in Supplementary Methods.
All experiments involving animals were performed in accordance with Italian national regulations and experimental protocols reviewed by local Institutional Animal Care and Use Committees (IACUC n. 574). Blastocyst preparation and immunofluorescence. Blastocysts from hyperovulated, mated C57Bl6 mice were obtained by flushing the uterine tubes with M2 medium (Sigma). Whole-mount immunofluorescence was performed as detailed previously 29 . Images were obtained with fluorescent microscopy (Zeiss Axiophot) or laser confocal microscopy (Ultra View, Perkin Elmer). Image slides were taken with a digital camera (Sensicam) using Image-Pro plus software.
Immunofluorescence on MEFs was performed as described previously 11 , after fixation for 10 min at 25 uC in 2% buffered paraformaldehyde, 3% sucrose in PBS, followed by permeabilization in 20 mM Hepes, pH 7.4, 0.5% Triton-X100. Polysomal profiles. Polysomal profiles were performed as described previously 10 . In brief, after measuring A 254 of the extracts prepared in 30 mM TrisHCl, pH 7.5, 100 mM NaCl, 30 mM MgCl 2 , 0.1% NP-40 and 10 mg ml 21 cycloheximide, the equivalent of 5 units of absorbance were layered on a 15-50% sucrose gradient and centrifuged at 4 uC in a SW41Ti Beckman rotor for 3 h 30 min at 39,000 r.p.m., corresponding to 190,000g. Absorbance at 254 nm was recorded by BioLogic LP software (BioRad). The preparation of individual ribosomal subunits and polysomes was obtained as detailed in Supplementary Methods. In brief, ribosomal subunits were dissociated by 20 mM EDTA after isolating them at 39,000 r.p.m. (190,000g) for 16 h on a 30% sucrose cushion then separated on a 10-30% sucrose gradient at 36,000 r.p.m. (160,000g) and analysed as above.
Analysis of rRNA metabolism in primary embryo fibroblasts was performed as detailed in Supplementary Methods. Primary cell cultures. Hepatocytes and primary MEFs were prepared from littermates and kept in culture for 3 h and 2-3 weeks, respectively. All the analyses were performed at least three times on different genetic backgrounds. Infection and rescue by eIF6-lentivirus was as detailed in Supplementary Information.
Primary embryo fibroblasts (MEFs) were prepared from E13.5 embryos and cultured as described 30 . In brief, embryos were dissociated by 0.03% trypsin in 0.2% EDTA at 37 uC for 10 min and then treated with DNaseI (New England Biolabs). After filtering fibroblasts with a 70 mm cell strainer, they were cultured in DMEM (Gibco) supplemented with 10% fetal bovine serum (FBS), 100 mg ml 21 streptomycin, 100 U ml 21 penicillin and 2 mM glutamine. MEFs were cultured at 9% CO 2 at 37 uC and experiments were performed at first passages (P1-P4). Hepatocytes were isolated as detailed in Supplementary Methods. Protein synthesis measurement by 35 S-methionine labelling. Primary embryo fibroblasts (MEFs) and primary hepatocytes were used for analysis of translational rate. Cells were seeded at sub-confluency in 6-well plates, and insulin stimulation was performed at 100 nM for 30 min. Metabolic labelling was performed as described previously 25 . All experiments were done in triplicate. Statistical P-values calculated by two-tailed t-test were also indicated: two asterisks for P-values less than 0.05 and one asterisk for P-values less than 0.01. Immunohistochemistry and histological staining. Immunohistochemical and histological analysis were performed on paraffin-embedded sections prepared as detailed in Supplementary Methods. Cell cycle analysis. S-phase entry was analysed by 3 H-thymidine assay on primary embryo fibroblasts at early passages. MEFs were seeded at 60% confluency in 6-well plate and starved for 48 h in DMEM plus 0.1% FBS. MEFs were then stimulated with 10% serum and labelled with 1 mC ml 21 3 H-thymidine for 24 h. 6, 9, 12, 15, 18, 21 and 24 h after serum addition, 3 H-thymidine was added to the medium and cells were lysed after 1 h as described in Supplementary Methods. Half of the radioactive sample obtained (0.5 ml) was solubilized in scintillation fluid and counted with a b-counter. Data derived from the mean of three independent experiments and counts per minute were normalized to the total amount of DNA. Retroviral infection and soft agar assay. The Phoenix ecotropic virus packaging cells were obtained from the American Tissue Culture Collection (ATCC) and maintained in DMEM supplemented with 10% FBS, 1% glutamine and antibiotics. The pBABE-hygro vector for expression of H-ras V12 , dominant-negative p53 mutant (DNp53) and Myc was described previously 30 . The soft agar formation assay and the focus formation assay were performed as described previously 30 . Southern blot and PCR analysis. Southern blot hybridization was used to identify the targeted allele in the embryonic stem cells using standard protocols. Specifically, targeted clones were identified by using a 59 external probe, which detects the change of a 16.3 kb wild-type EcoRV fragment to a novel 13 kb EcoRV fragment, and then were confirmed with a 39 external probe, which detects the change of a 13.3 kb wild-type HindIII fragment into a novel 9.2 kb HindIII fragment.
Genotyping of the offspring mice was performed using a three-primers PCR strategy to simultaneously amplify target sequences from both the wild-type and the mutant alleles. PCR was performed by AmpliTaq Gold (Roche) according to the manufacturer's protocol. A shared primer number 3 (59-GTG AGTCTTGGCTTCATGTG-39) was designed downstream of the deleted region. This primer can pair with wild-type allele-specific primer number 2 (59-CTATGTGGCCTTGGTCCAC-39) to amplify a 320 bp PCR product or with the targeted allele-specific primer number 1 (59-GCAGCGCATCGCCTTC TATC-39) in the neo cassette to amplify a 650 bp fragment from the mutant allele. PCR products were resolved on 2% agarose gel. Immunohistochemistry and histological staining. Tissue samples were excised from eIF6 1/1 and eIF6 1/2 mice and immediately fixed in 10% formaldehyde in 0.1 M phosphate buffer (PBS) at pH 7.4. Serial 3-mm sections of paraffin-embedded liver, skin and fat were stained with haematoxylin and eosin (H&E) for morphological analysis. Liver sections were subjected to immunohistochemical staining for proliferating cell nuclear antigen (PCNA) using the Vectastain Elite ABC kit (Vector). In brief, slides were passed in graded alcohol solutions, rinsed in distilled water and immersed in citrate buffer (0.1 M citric acid plus 0.1 M sodium citrate). Samples were boiled in a microwave oven three times for 5 min, washed in PBS and soaked in 3% hydrogen peroxide for 30 min to block endogenous peroxidase activity. After blocking in normal serum, slides were incubated with anti-PCNA (1:2,000) for 16 h at 4 uC. Sections were incubated with a biotinylated secondary antibody for 1 h at room temperature and then with a preformed avidin-biotinylated peroxidase complex. Signals were detected using diaminobenzidine tetrahydrochloride (DAB, BioGENEX) and sections were counterstained with haematoxylin. Stained samples were observed in a Zeiss Axiophot microscope and pictures were acquired with ScionImage Software. siRNA transfection of NIH 3T3 cells. Transient transfection was performed on NIH 3T3 cells using Lipofectamin 2000 (Invitrogen), according to manufacturer's instructions.
For siRNA experiments, siGENOME duplex targeting ITGB4BP was used (NM_002212; sense sequence, 59-GAGCUUCGUUCGAGAACAAUU-39; antisense sequence, 59-PUUGUUCUCGAACGAAGCUCUU-39; Dharmacon). SiCONTROL NON-TARGETING siRNA POOL (Dharmacon) was used as negative control.
Cells were transfected at 30-40% confluency using 100 pmol siRNA in Opti-MEM medium (Invitrogen); after 3 h at 37 uC the medium was changed, and gene silencing was examined by western blot analysis 72 h after transfection. Flow cytometry and measurement of cell size. Unfixed eIF6
1/1 and eIF6
iodide (Sigma). Cell size (FSC) was analysed using FACS Canto II (Becton Dickinson). Cell fractionation. Cells were detached by trypsinization and collected by centrifugation. The pellet was resuspended in ice-cold hypotonic wash buffer (10 mM Tris HCl, pH 7.4, 10 mM KCl, 2 mM MgCl 2 ) and then the cytoplasmic fraction was extracted in hypotonic lysis buffer (10 mM Tris HCl, pH 7.4, 10 mM KCl, 2 mM MgCl 2 , 0.05% Triton X-100, 1 mM EGTA, 1 mM DTT) for 20 min on ice. Nuclei were collected by centrifugation at 700g for 15 min and resuspended in hypotonic wash buffer before loading on 1.6 M sucrose cushion for nuclear fraction purification. The nuclear pellet was obtained by ultracentrifugation (TL100, Beckman) at 50,000 r.p.m. for 1 h and then lysed in RIPA buffer. Lentiviral infection. 293T cells (ATCC) were infected with packaging plasmid VSV-G, PMDLg/pRRE, pREV and transfer vector pCCL-PPT-hPGK-pre previously described 31 . Full-length eIF6 and GFP were cloned in transfer vector. MEFs were infected with eIF6-pCCL and GFP-pCCL at early passage (P 1 ) and used for 35 S-methionine labelling as described. Multiplicity of infection (m.o.i.) was empirically determined to achieve twofold eIF6 expression by triplicate infections.
In vitro mutagenesis was performed on the wild-type eIF6 lentiviral transfer plasmid by the QuickChange Kit (Stratagene) using the same oligonucleotides as in ref. 32 . Ear mesenchymal stem cell culture and adipogenesis. Mesenchymal stem cells from outer ears of eIF6 1/1 and eIF6 1/2 mice were collected and differentiated into the adipogenic lineage as previously described 33 . Differentiated cells were fixed in 10% buffered formaline and stained with Oil Red O for 10 min. The dye retained by the cells was eluted with isopropanol and quantified by measuring absorbance at 500 nm. Polysomal profile from liver. Tissue was gently homogenized in 50 mM Tris HCl, pH 7.8, 240 mM KCl, 10 mM MgSO 4 , 5 mM DTT, 250 mM sucrose, 2% Triton X-100, 90 mg ml 21 cicloheximide and 30 U ml 21 RNasin using a glass douncer. After clarification, 100 mg ml 21 heparin was added to the supernatant. 5 OD 254 of rRNA was loaded on a 15-55% sucrose gradient dissolved in 25 mM Tris HCl, pH 7.4, 25 mM NaCl, 5 mM MgCl 2 and 1 mM DTT and run at 39,000 r.p.m. (190,000g) for 3 h 30 min with SW41Ti swing rotor (Beckman Coulter). The polysomal profile was detected at as previously described. RNA blot analysis. Total RNA was isolated from MEF cells or from mouse liver using TRI REAGENT (Sigma) following the manufacturer's protocol. RNA (5 mg) was separated on 1% agarose-formaldehyde gel and analysed by northern blot hybridization using standard techniques.
The oligonucleotide ITS2-2 complementary to nucleotides 239-271 of the ITS2 region was use as probe for hybridization (59-ACTGGTGAGGCA GCGGTCCGGGAGGCGCCGACG-39), as described previously 34 . The probe was 59-labelled using [c- 32 P] ATP and T4 polynucleotide kinase. Preparation of 40S and 60S ribosomal subunits. Dissociation of 40S and 60S ribosomal subunits extracted from cytoplasmic and nuclear compartments were obtained as described previously 20 . 40S and 60S subunits were dissociated with 20 mM EDTA. The equivalent of 20 units of A 254 of total rRNA were loaded on a 30% sucrose cushion dissolved in 10 mM Tris HCl, pH 7.5, 10 mM KCl, 1 mM MgCl 2 and 1 mM DTT. Ribosomal RNA was collected by ultracentrifugation at 36,000 r.p.m. for 16 h, washed twice in cold 13 PBS and resuspended in 30 mM Tris HCl, pH 7.5, 10 mM KCl, 1 mM MgCl 2 , 20 mM EDTA and 1 mM DTT. 10 OD of dissociated 40S and 60S subunits were separated through a 10-30% 
